CYTK
Price
$36.89
Change
-$6.03 (-14.05%)
Updated
May 2, 02:39 PM (EDT)
Capitalization
5.12B
4 days until earnings call
OTLK
Price
$1.58
Change
+$0.01 (+0.64%)
Updated
May 2, 02:42 PM (EDT)
Capitalization
51.21M
Ad is loading...

CYTK vs OTLK

Header iconCYTK vs OTLK Comparison
Open Charts CYTK vs OTLKBanner chart's image
Cytokinetics
Price$36.89
Change-$6.03 (-14.05%)
Volume$5.2K
Capitalization5.12B
Outlook Therapeutics
Price$1.58
Change+$0.01 (+0.64%)
Volume$100
Capitalization51.21M
CYTK vs OTLK Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. OTLK commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and OTLK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (CYTK: $42.92 vs. OTLK: $1.57)
Brand notoriety: CYTK and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 93% vs. OTLK: 55%
Market capitalization -- CYTK: $5.12B vs. OTLK: $51.21M
CYTK [@Biotechnology] is valued at $5.12B. OTLK’s [@Biotechnology] market capitalization is $51.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileOTLK’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • OTLK’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than OTLK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while OTLK’s TA Score has 6 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 4 bearish.
  • OTLK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OTLK is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а +6.42% price change this week, while OTLK (@Biotechnology) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +8.32%, and the average quarterly price growth was -5.52%.

Reported Earning Dates

CYTK is expected to report earnings on Jul 31, 2025.

OTLK is expected to report earnings on May 15, 2024.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.12B) has a higher market cap than OTLK($51.2M). CYTK YTD gains are higher at: -8.759 vs. OTLK (-16.931). OTLK has higher annual earnings (EBITDA): -83.38M vs. CYTK (-493.48M). CYTK has more cash in the bank: 1.08B vs. OTLK (5.7M). OTLK has less debt than CYTK: OTLK (31M) vs CYTK (789M). CYTK has higher revenues than OTLK: CYTK (18.5M) vs OTLK (0).
CYTKOTLKCYTK / OTLK
Capitalization5.12B51.2M9,992%
EBITDA-493.48M-83.38M592%
Gain YTD-8.759-16.93152%
P/E RatioN/AN/A-
Revenue18.5M0-
Total Cash1.08B5.7M18,867%
Total Debt789M31M2,545%
FUNDAMENTALS RATINGS
CYTK vs OTLK: Fundamental Ratings
CYTK
OTLK
OUTLOOK RATING
1..100
2631
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTLK's Valuation (86) in the Biotechnology industry is in the same range as CYTK (100). This means that OTLK’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for OTLK (100). This means that CYTK’s stock grew somewhat faster than OTLK’s over the last 12 months.

CYTK's SMR Rating (99) in the Biotechnology industry is in the same range as OTLK (99). This means that CYTK’s stock grew similarly to OTLK’s over the last 12 months.

CYTK's Price Growth Rating (61) in the Biotechnology industry is in the same range as OTLK (64). This means that CYTK’s stock grew similarly to OTLK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for OTLK (100). This means that CYTK’s stock grew significantly faster than OTLK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKOTLK
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
77%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TMV36.620.70
+1.95%
Direxion Daily 20+ Yr Trsy Bear 3X ETF
BBSC59.530.55
+0.94%
JPMorgan BetaBuilders US Sml Cp Eq ETF
ETY13.980.12
+0.87%
Eaton Vance Tax-Managed Diversified Equity Income Fund
QQJG22.00N/A
N/A
Invesco ESG NASDAQ Next Gen 100 ETF
FPFD21.06-0.02
-0.10%
Fidelity Preferred Securities & Inc ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IDYA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+0.19%
IDYA - CYTK
48%
Loosely correlated
+1.69%
ACLX - CYTK
46%
Loosely correlated
+0.89%
KRYS - CYTK
46%
Loosely correlated
-2.47%
TRDA - CYTK
43%
Loosely correlated
-0.88%
DNLI - CYTK
43%
Loosely correlated
-3.54%
More

OTLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with HEPA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then HEPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
N/A
HEPA - OTLK
34%
Loosely correlated
+0.93%
CYTK - OTLK
33%
Loosely correlated
+0.19%
PDSB - OTLK
33%
Loosely correlated
-5.00%
MCRB - OTLK
32%
Poorly correlated
-2.06%
VIR - OTLK
31%
Poorly correlated
-0.65%
More